Healthcare data firm Apixio has appointed Jonathan Murray as its new chief business development officer.
Murray will lead strategic sales and business development activities at Apixio, which provides both clinical data integration and big data analytics for organisations working in healthcare.
He joins from US health insurance firm Aetna, where he served as senior VP, business development and market head for mid-America.
Prior to his time at Aetna, Murray held sales and business development leadership roles at Anvita Health and Resolution Health – two healthcare start-ups that were acquired by Humana and Wellpoint respectively.
“Jonathan’s unique insights into the rapidly changing healthcare industry will deliver deep value to Apixio’s clients including payers, providers and technology partners,” said Shawn Dastmalchi, CEO of Apixio.
“His experience developing value-based performance programmes will be invaluable as our partners navigate this evolving healthcare environment. We look forward to creating and deepening our strategic partnerships with Jonathan’s leadership and business development efforts.”